Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 27 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
261 23.0 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Institut Gustave Roussy France 4/2013
Treatment Details: Patients: This phase 2 study involved metastatic colorectal cancer patients who were separated into two different treatment groups. Group A consisted of 72 patients with a median age of 61
 
262 23.0 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
Hormone
Osaka University Japan 6/2012
Treatment Details: Patients: This study involved 72 men with metastatic castration-resistant prostate cancer. The median patient age was 72 years. Treatment: Patients were treated with the chemotherapy
 
263 22.9 months Adenocarcinoma of the lung 5 Chemotherapy
National Cancer Center Korea 2/2012
Treatment Details: Patients: This phase III study involved never-smokers with adenocarcinoma of the lung who had not received previous chemotherapy. Patients were separated into 2 treatment groups. Group A
 
264 22.8 months Metastatic colorectal carcinoma 5 Biologic therapy
Chemotherapy
Martin Luther University Halle-Wittenberg Germany 10/2012
Treatment Details: Patients: This phase 3 study involved untreated metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 709 patients with a median a
 
265 22.8 months ALK-positive lung cancer 5 Chemotherapy
Massachusetts General Hospital United States 6/2013
Treatment Details: Patients: This phase 3 study involved ALK-positive lung cancer patients who had received prior platinum-based chemotherapy. Patients were divided into two separate treatment groups. Group
 
266 22.7 months NSCLC 5 Biologic therapy
Chemotherapy
Radiation
MD Anderson Cancer Center United States 6/2010
Treatment Details: Patients: This phase II study involved 87 patients with stage IIIA/B non-small cell lung cancer. Of these, the median age was 64 years and 57% were male. Treatment: Patients in this st
 
267 22.7 months metastatic breast cancer 5 Biologic therapy
Chemotherapy
National Cancer Institute Italy 3/2007
Treatment Details: Patients: This phase II trial enrolled 50 women (median age of 54, ranging from 31-81), and 41 were able to be in the study. Of these, 26 had one prior course of chemotherapy and 15 had two
 
268 22.7 months metastatic breast cancer 4 Chemotherapy
Hospital Saint Louis France 7/2005
Treatment Details: Patients: This Phase II study involved 186 women with metastatic breast cancer. Ninety-two women (median age 53) were randomly assigned into Group A, and ninety-four (median age 55) were pla
 
269 22.6 months metastatic breast cancer 4 Chemotherapy
Erasmus University Medical Center Netherlands 10/2005
Treatment Details: Patients: This Phase II/III study involved 216 women with metastatic breast cancer who were randomly assigned into two groups. Group A had 109 women (median age 53). Metastatic sites inclu
 
270 22.6 months Unresectable metastatic colorectal 4 Chemotherapy
University of Pisa Italy 5/2007
Treatment Details: Patients: This phase III trial involved 244 patients with unresectable metastatic colorectal cancer. They were divided into two groups of 122. In arm 1, 57% were men and 43 were women. S
 
Page 27 of 187  | Previous Page  | Next Page